SK Biopharmaceuticals Co Ltd
KRX:326030

Watchlist Manager
SK Biopharmaceuticals Co Ltd Logo
SK Biopharmaceuticals Co Ltd
KRX:326030
Watchlist
Price: 104 000 KRW -0.1% Market Closed
Market Cap: 8.1T KRW
Have any thoughts about
SK Biopharmaceuticals Co Ltd?
Write Note

SK Biopharmaceuticals Co Ltd
Income to Minority Interest

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

SK Biopharmaceuticals Co Ltd
Income to Minority Interest Peer Comparison

Comparables:
000100
008930
128940
S
000250
C
068760

Competitive Income to Minority Interest Analysis
Latest Figures & CAGR of Competitors

Company Income to Minority Interest CAGR 3Y CAGR 5Y CAGR 10Y
SK Biopharmaceuticals Co Ltd
KRX:326030
Income to Minority Interest
â‚©2.5B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Yuhan Corp
KRX:000100
Income to Minority Interest
â‚©4.1B
CAGR 3-Years
-1%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Hanmi Science Co Ltd
KRX:008930
Income to Minority Interest
â‚©1.2B
CAGR 3-Years
550%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Hanmi Pharm Co Ltd
KRX:128940
Income to Minority Interest
-â‚©22.8B
CAGR 3-Years
-40%
CAGR 5-Years
-15%
CAGR 10-Years
-13%
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Income to Minority Interest
-â‚©6.3B
CAGR 3-Years
-4%
CAGR 5-Years
2%
CAGR 10-Years
-26%
C
Celltrion Pharm Inc
KOSDAQ:068760
Income to Minority Interest
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is SK Biopharmaceuticals Co Ltd's Income to Minority Interest?
Income to Minority Interest
2.5B KRW

Based on the financial report for Dec 31, 2023, SK Biopharmaceuticals Co Ltd's Income to Minority Interest amounts to 2.5B KRW.

Back to Top